Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future

Panoraia Siafaka1, Esra Ipekci2, Emre Şefik Caglar2

  • 1Aristotle University of Thessaloniki, Department of Chemistry, Thessaloniki, Greece.

Insights

Developing pediatric medications is challenging due to children's unique physiology and formulation needs. This review summarizes child-friendly drug delivery systems to improve pediatric patient care and safety.

Area of Science:

  • Pediatric Pharmacology
  • Drug Delivery Systems
  • Pharmaceutical Sciences

Background:

  • Children face unique health challenges, including rare illnesses.
  • Pediatric drug development is complex due to difficulties with standard dosage forms (e.g., tablets) and unlicensed medications.
  • Pediatric dosing differs significantly from adults, influenced by age-related variations in drug absorption, distribution, metabolism, and elimination (ADME).

Purpose of the Study:

  • To review current drug formulations for pediatric patients.
  • To summarize approaches for developing child-friendly drug delivery systems.
  • To aid professionals in designing more efficient and safer pediatric medications.

Main Methods:

  • Literature review of existing pediatric formulations.
  • Summary of therapeutic approaches for pediatric drug delivery.
  • Analysis of challenges in pediatric medication administration.

Main Results:

  • Various formulations like liquid dosage forms and flexible capsules are used for pediatric patients.
  • Children's sensitivity to taste and smell impacts medication adherence.
  • Infants are at higher risk for adverse drug events from adult medications.

Conclusions:

  • Effective pediatric formulations require consideration of age-specific ADME and patient acceptance.
  • Development of child-friendly drug delivery systems is crucial for improving therapeutic outcomes and safety in children.
  • This review provides insights for professionals aiming to create better pediatric drug formulations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
45
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
59
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
59
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K